Itron (NASDAQ:ITRI – Get Free Report) updated its FY 2026 earnings guidance on Tuesday. The company provided EPS guidance of 6.300-6.500 for the period, compared to the consensus estimate of 5.980. The company issued revenue guidance of $2.4 billion-$2.4 billion, compared to the consensus revenue estimate of $2.4 billion. Itron also updated its Q3 2026 guidance to 1.500-1.600 EPS.
Wall Street Analyst Weigh In
A number of brokerages recently issued reports on ITRI. Stephens reiterated an “overweight” rating and issued a $130.00 price target on shares of Itron in a research note on Wednesday, May 20th. Oppenheimer raised their price objective on shares of Itron from $133.00 to $135.00 and gave the company an “outperform” rating in a research note on Thursday, April 16th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Itron in a report on Friday, May 8th. Roth Capital reiterated a “buy” rating and issued a $136.00 target price on shares of Itron in a research note on Wednesday, April 29th. Finally, Raymond James Financial started coverage on shares of Itron in a research note on Tuesday, April 21st. They issued an “underperform” rating on the stock. Eight equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $131.22.
Read Our Latest Analysis on ITRI
Itron Stock Performance
Itron (NASDAQ:ITRI – Get Free Report) last released its quarterly earnings data on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.29 by $0.30. Itron had a net margin of 12.31% and a return on equity of 19.54%. Itron’s quarterly revenue was down 7.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.62 earnings per share. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS. Sell-side analysts predict that Itron will post 6.01 earnings per share for the current fiscal year.
Insider Buying and Selling at Itron
In other news, SVP Donald L. Reeves III sold 319 shares of the firm’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total value of $26,914.03. Following the transaction, the senior vice president directly owned 29,100 shares in the company, valued at $2,455,167. This trade represents a 1.08% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP John F. Marcolini sold 322 shares of the firm’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total value of $27,167.14. Following the completion of the transaction, the senior vice president owned 24,689 shares in the company, valued at approximately $2,083,010.93. This trade represents a 1.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 3,946 shares of company stock worth $324,420. Insiders own 1.77% of the company’s stock.
Trending Headlines about Itron
Here are the key news stories impacting Itron this week:
- Positive Sentiment: Non-GAAP diluted EPS was $1.59, exceeding analysts’ consensus estimate of $1.29 by $0.30. Adjusted EBITDA rose 8% to $97 million, and adjusted gross margin reached a record 41.4%, up 460 basis points year over year. Itron Announces Second Quarter 2026 Financial Results
- Positive Sentiment: Itron raised its full-year 2026 non-GAAP EPS outlook to $6.30-$6.50, above the roughly $5.98 analyst consensus, signaling confidence in improving operating performance and demand across utility and infrastructure markets. Full-year revenue guidance is $2.37-$2.41 billion.
- Positive Sentiment: Annual recurring revenue increased 21% to $417 million, while Outcomes revenue grew 13%. The company also reported $550 million in quarterly bookings and a substantial $4.4 billion backlog, supporting longer-term visibility.
- Neutral Sentiment: Third-quarter guidance calls for non-GAAP EPS of $1.50-$1.60, broadly around consensus of $1.55, but revenue of $590-$600 million is below the $607.4 million estimate. This suggests earnings may remain resilient even as project timing weighs on sales.
- Negative Sentiment: Second-quarter revenue fell 7% to $563 million, primarily because Networked Solutions revenue declined 17% amid lower volumes and project-deployment timing. Device Solutions revenue also edged lower.
- Negative Sentiment: GAAP net income attributable to Itron dropped to $53 million from $68 million, and GAAP diluted EPS declined to $1.19 from $1.47. Non-GAAP EPS also slipped slightly from $1.62 a year earlier, while free cash flow decreased to $81 million from $91 million.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of the company. Dimensional Fund Advisors LP grew its stake in shares of Itron by 18.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,271,042 shares of the scientific and technical instruments company’s stock valued at $118,034,000 after purchasing an additional 194,768 shares during the period. First Trust Advisors LP lifted its stake in shares of Itron by 4.1% in the 4th quarter. First Trust Advisors LP now owns 793,175 shares of the scientific and technical instruments company’s stock worth $73,654,000 after purchasing an additional 31,088 shares during the period. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Itron by 42.5% in the third quarter. Arrowstreet Capital Limited Partnership now owns 604,580 shares of the scientific and technical instruments company’s stock worth $75,306,000 after buying an additional 180,366 shares during the last quarter. Schroder Investment Management Group boosted its holdings in shares of Itron by 65.2% in the fourth quarter. Schroder Investment Management Group now owns 588,872 shares of the scientific and technical instruments company’s stock worth $54,683,000 after buying an additional 232,341 shares during the last quarter. Finally, Millennium Management LLC grew its position in Itron by 269.3% during the fourth quarter. Millennium Management LLC now owns 506,867 shares of the scientific and technical instruments company’s stock valued at $47,068,000 after buying an additional 369,617 shares during the period. 96.19% of the stock is owned by hedge funds and other institutional investors.
Itron Company Profile
Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.
Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.
Recommended Stories
- Five stocks we like better than Itron
- 5 Space Stocks Face a Brutal Correction: Which Ones Are Still Buys?
- Whirlpool’s Report May Show How Frozen the Housing Market Really Is
- 3 Stocks Standing Out and 2 Losing Momentum as the Tech Rally Cracks
- 5 AI Stocks Are Pulling Back—Which Growth Catalysts Still Look Strongest?
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.
